Tagrisso
Term · Oncology and biomedicine · MLC-T-ONC-008495
A drug used alone or with other drugs to treat adults with certain types of non-small cell lung cancer that have an abnormal EGFR gene. It is also being studied in the treatment of other types of cancer. Tagrisso blocks certain proteins made by the mutated EGFR gene, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called osimertinib mesylate.
| Identifier | MLC-T-ONC-008495 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | osimertinib mesylate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008495",
"term": "Tagrisso",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat adults with certain types of non-small cell lung cancer that have an abnormal EGFR gene. It is also being studied in the treatment of other types of cancer. Tagrisso blocks certain proteins made by the mutated EGFR gene, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called osimertinib mesylate.",
"synonyms": [
"osimertinib mesylate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/tagrisso/"
}
Record 15,952 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.